Ribocure Pharmaceuticals Ab
Clinical trials sponsored by Ribocure Pharmaceuticals Ab, explained in plain language.
-
New drug RBD4059 tested for heart disease safety
Disease control OngoingThis study tests a new drug called RBD4059 in 30 adults with stable coronary artery disease. The main goal is to check if the drug is safe and to see how it affects the body compared to a placebo. Participants will receive either the drug or a placebo and visit the clinic up to 1…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated May 17, 2026 05:28 UTC
-
New hope for rare liver infection: drug trial underway
Disease control OngoingThis study tests a new drug called RBD1016 in 14 adults with chronic hepatitis D, a serious liver infection. The goal is to see if the drug can lower the amount of virus in the blood and check for any side effects. Participants receive either RBD1016 or a placebo and visit the cl…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC